"cancer biomarker" trang 13 - tải miễn phí từ tailieunhanh
Total DNA methylation as a biomarker of DNA damage and tumor malignancy in intracranial meningiomas

Total DNA methylation as a biomarker of DNA damage and tumor malignancy in intracranial meningiomas
13    63    0
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: A case report

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: A case report
4    63    0
Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma

Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma
8    65    0
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma

VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma
7    40    1
Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigenspecific IgA seropositive population

Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigenspecific IgA seropositive population
7    58    1
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
9    57    1
P53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma

P53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma
8    36    1
PODXL might be a new prognostic biomarker in various cancers: A metaanalysis and sequential verification with TCGA datasets

PODXL might be a new prognostic biomarker in various cancers: A metaanalysis and sequential verification with TCGA datasets
13    52    1
Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: A retrospective study

Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: A retrospective study
8    43    1
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: The combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies

INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: The combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies
11    58    1
Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma

Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma
7    59    1
A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients

A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients
13    50    1
Tumor classification and biomarker discovery based on the 5’isomiR expression level

Tumor classification and biomarker discovery based on the 5’isomiR expression level
10    49    1
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
13    31    1
Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma

Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma
12    43    1
Protocol of the PANCALYZE trial: A multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease

Protocol of the PANCALYZE trial: A multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease
9    53    1
SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy
8    72    1
Intrahepatic cholangiocarcinoma prognostic determination using preoperative serum C-reactive protein levels

Intrahepatic cholangiocarcinoma prognostic determination using preoperative serum C-reactive protein levels
10    53    1
Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker

Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker
7    63    1
A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma

A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma
9    48    1